Chembio diagnostics, Inc.
CEMI
CEMI was delisted on the 27th of April, 2023.
30 hedge funds and large institutions have $1.36M invested in Chembio diagnostics, Inc. in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 12 reducing their positions, and 10 closing their positions.
175% more call options, than puts
Call options by funds: $11K | Put options by funds: $4K
112% more capital invested
Capital invested by funds: $643K → $1.36M (+$718K)
21% less funds holding
Funds holding: 38 → 30 (-8)
58% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 12
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
PenderFund Capital Management
Vancouver,
British Columbia, Canada
|
+$57.8K |
| 2 |
HF
HRT Financial
New York
|
+$37.8K |
| 3 |
VF
Virtu Financial
New York
|
+$24.6K |
| 4 |
Renaissance Technologies
New York
|
+$8.11K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$7.32K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$12.5K |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$11.5K |
| 3 |
VA
Valmark Advisers
Akron,
Ohio
|
-$11.3K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$7.64K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$7.46K |
CEMI Hedge Fund Activity: Q1 2023 in Review
30 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q1 2023, worth a combined $1.36M — up 112% from $643K a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of CEMI and 3 opened new positions — a net loss of 7 holders — while 12 trimmed existing stakes and 5 added.
The largest buyer was PenderFund Capital Management, opening a new position worth an estimated $57.8K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $12.5K sold.
- 30 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q1 2023, down from 38 in Q4 2022.
- Funds reported $1.36M of Chembio diagnostics, Inc. stock for Q1 2023, up 112% quarter-over-quarter.
- 3 funds opened new Chembio diagnostics, Inc. positions in Q1 2023 and 10 closed out, a net change of -7 holders.
- The largest Chembio diagnostics, Inc. buyer in Q1 2023 was PenderFund Capital Management, an estimated $57.8K added.
- The largest Chembio diagnostics, Inc. seller in Q1 2023 was Susquehanna International Group, an estimated $12.5K sold.
Based on aggregated 13F filings for Q1 2023.